União Europeia -
norueguês -
EMA (European Medicines Agency)
xalkori
pfizer europe ma eeig - crizotinib - karsinom, ikke-småcellet lunge - antineoplastiske midler - xalkori as monotherapy is indicated for:the first‑line treatment of adults with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc)the treatment of adults with previously treated anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc)the treatment of adults with ros1‑positive advanced non‑small cell lung cancer (nsclc)the treatment of paediatric patients (age ≥6 to.
Noruega -
norueguês -
Statens legemiddelverk
rivastigmin orion 3 mg
orion corporation - espoo - rivastigminhydrogentartrat - kapsel, hard - 3 mg
Noruega -
norueguês -
Statens legemiddelverk
rivastigmin orion 1.5 mg
orion corporation - espoo - rivastigminhydrogentartrat - kapsel, hard - 1.5 mg
Noruega -
norueguês -
Statens legemiddelverk
rivastigmin orion 4.5 mg
orion corporation - espoo - rivastigminhydrogentartrat - kapsel, hard - 4.5 mg
Noruega -
norueguês -
Statens legemiddelverk
rivastigmin orion 6 mg
orion corporation - espoo - rivastigminhydrogentartrat - kapsel, hard - 6 mg
Noruega -
norueguês -
Statens legemiddelverk
prograf 0.5 mg
astellas pharma a/s - takrolimusmonohydrat - kapsel, hard - 0.5 mg
Noruega -
norueguês -
Statens legemiddelverk
prograf 1 mg
astellas pharma a/s - takrolimusmonohydrat - kapsel, hard - 1 mg
Noruega -
norueguês -
Statens legemiddelverk
prograf 5 mg
astellas pharma a/s - takrolimusmonohydrat - kapsel, hard - 5 mg
União Europeia -
norueguês -
EMA (European Medicines Agency)
bronchitol
pharmaxis europe limited - mannitol - cystisk fibrose - hoste og kalde preparater - bronchitol er indisert for behandling av cystisk fibrose (cf) hos voksne i alderen 18 år og over som en tilleggsbehandling til den beste pasientstandarden.
Noruega -
norueguês -
Statens legemiddelverk
sevikar 40 mg / 5 mg
daiichi sankyo europe gmbh - olmesartanmedoksomil / amlodipinbesilat - tablett, filmdrasjert - 40 mg / 5 mg